Overview

Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia

Status:
Withdrawn
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether preventative treatment with sarcosine can reduce symptoms and delay/avoid disease progression in individuals defined as being in a prodromal stage of schizophrenia.
Phase:
Phase 2
Details
Lead Sponsor:
Herzog Hospital